Related Experiment Video

Updated: Jun 8, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Epigenetics and microRNAs combine to modulate the MDM2/p53 axis in myeloma

Marta Chesi1, P Leif Bergsagel

  • 1Mayo Clinic in Arizona, Scottsdale, 85259, USA.

Cancer Cell
|October 19, 2010
PubMed

Insights

Tumor progression often requires overcoming p53

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Tumorigenesis is frequently associated with the inactivation of tumor suppressor proteins like p53.
  • Multiple myeloma (MM) typically retains p53 functionality, presenting a unique therapeutic challenge.
  • MicroRNAs (miRNAs) are critical regulators of gene expression, often dysregulated in cancer.

Discussion:

  • This study investigates the epigenetic silencing of microRNAs targeting MDM2 in multiple myeloma.
  • MDM2 is a key negative regulator of p53, and its targeting by miRNAs is crucial for p53 pathway modulation.
  • Epigenetic silencing of these miRNAs may allow for MDM2 overexpression, potentially contributing to tumor progression despite intact p53.

Key Insights:

  • Epigenetic silencing of MDM2-targeting microRNAs is identified as a mechanism in multiple myeloma.
  • This silencing circumvents the inhibitory effects of p53 on cell growth, facilitating tumor progression.
  • The findings highlight a novel therapeutic vulnerability in multiple myeloma.

Outlook:

  • MicroRNA-targeted therapies hold promise for treating multiple myeloma by restoring the function of tumor suppressive pathways.
  • Further research into epigenetic mechanisms controlling miRNA expression in MM is warranted.
  • This work may inform the development of novel therapeutic strategies for p53-proficient cancers.

More Related Videos

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...